PCNA and COVID-19: To further assess renal damage in patients with COVID-19, we examined proliferating cell nuclear antigen (PCNA) as a marker of increased repair and the expression of the endothelial cell marker ERG in COVID-19 kidney biopsies and compared these to biopsies of kidney diseases characterized by tubular or endothelial damage.